Psyence Biomedical Ltd.
13F holders, Q3 2024 (September 30)12holders +2
5new positions
3sold out
1famous investor
$0.10avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Psyence Biomedical Ltd. in their 13F filings, up 2 from Q2 2024. 5 opened new positions and 3 sold out. The largest holders were AdvisorShares Investments LLC ($123K), Cantor Fitzgerald, L. P. ($34K) and Citadel Advisors ($17K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F100
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $35K |
| Exits | 3 | $10K |
All 13F filers, Q2 2024 → Q3 2024: 1,150,523 shares bought and 42,779 shares sold, net +1,107,744 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| AdvisorShares Investments LLC | 0.02% | Add +166.2% | 1,232,376 | $123K |
| Cantor Fitzgerald, L. P. | 0.00% | No change | 337,000 | $34K |
| Citadel Advisors | 0.00% | New | 169,251 | $17K |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | New | 80,500 | $8K |
| Morgan Stanley | 0.00% | Add +142.0% | 48,407 | $5K |
| Jane Street Group, LLC | 0.00% | New | 45,963 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 34,391 | $3K |
| HRT Financial LP | 0.00% | Add +42.5% | 25,765 | $2K |
| UBS Group AG | 0.00% | Reduce -34.3% | 15,030 | $2K |
| Two Sigma Securities, LLC | 0.00% | New | 14,989 | $1K |
| Geode Capital Management, LLC | 0.00% | No change | 10,488 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.